US Stock MarketDetailed Quotes

SPRY ARS Pharmaceuticals

Watchlist
  • 9.240
  • +0.220+2.44%
Close Apr 15 16:00 ET
  • 9.000
  • -0.240-2.60%
Post 18:27 ET
891.67MMarket Cap-16210P/E (TTM)

About ARS Pharmaceuticals Company

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

Company Profile

SymbolSPRY
Company NameARS Pharmaceuticals
Listing Date12/04/2020
Founded2015
CEOMr. Richard E. Lowenthal, M.B.A.,M.S.
MarketNASDAQ
Employees26
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address11682 El Camino Real,Suite 120
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-206-456-2900
Websitehttp://www.ars-pharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Richard E. Lowenthal, M.B.A.,M.S.
  • President, Chief Executive Officer and Director
  • 476.35K
  • Alexander A. Fitzpatrick
  • Chief Legal Officer and Secretary
  • --
  • Brian T. Dorsey
  • Chief Operating Officer
  • --
  • Kathleen D. Scott
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Sarina Tanimoto, M.B.A.,M.D.
  • Chief Medical Officer
  • 338.15K
  • Eric Karas
  • Chief Commercial Officer
  • 222.62K
  • Justin Chakma
  • Chief Business Officer
  • 2.28M
  • Dr. Pratik Shah, PhD
  • Chairman of the Board
  • 50.36K
  • Brenton L. Saunders
  • Director
  • 5.92K
  • Dr. Laura Shawver, PhD
  • Director
  • 5.82M
  • Saqib Islam, J.D.
  • Director
  • 149.05K
  • Dr. Peter A. Thompson,M.D.,F.A.C.P.
  • Independent Director
  • 125.33K
  • Phillip M. Schneider
  • Independent Director
  • 8.88K
  • Dr. Peter Kolchinsky, PhD
  • Independent Director
  • 8.14K
  • Dr. Rajeev Dadoo, PhD
  • Independent Director
  • 9.62K
  • Michael Kelly
  • Independent Director
  • 7.40K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg